-
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
-
Dentists now are coming in to the fold of DNA genomics tests. This test is very specific to assess risk for periodontal disease, so as a younger patient, as chances are as we age if we are at risk we may already have this, this could be a good indicator for the dentist to have in the knowledge...
-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-06-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, DNA, Genomics, Research, Pharmacogenomics, MIT, Biomed, Broad Institute, Harvard
-
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...
-
This is good, a genomics test that can give some preliminary results on whether or not statins will have an adverse effect before prescribing them. As the post states here, this is something that could certainly use some marketing to physicians. Zocor at 40 mg is a very common dosage and...
-
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
-
This gives a whole new meaning to the old redneck slang term of “swapping spit”. One more way to market oneself through genetics and single life. One question comes to mind, can they do this in California and New York? Even though the web site states this is specifically for dating...
-
An executive of the company had his own DNA tested and the results were shocking and unexpected to say the least. Recently deCode Genetics spoke about working more with physicians in the education process of personalized medicine . The test ran by the company he works for showed that he...
-
Warfarin is the second-most-likely drug, to cause adverse events requiring hospitalization. The use of warfarin sensitivity testing in the U.S. could avoid 85,000 serious-bleeding incidents. More in the way of personalized medicine and if you were a patient determined to have an adverse reaction...
-
This is very interesting and thanks to Medgadget for finding this one. Will we someday be listening to cancer genes and perhaps others? If you would like to hear what the genes sound like, here’s the page. I do have to say that this is a very interesting concept whereby I wonder if...
-
Not too many years ago I remembered hearing the term “hospitalist” and asked what’s that? The hospitalist has evolved and is now one of the top growing professions. With Pharmacogenomics, we might be on the verge of a new specialty, a “Longevity Doctor”. We already have a dwindling...
-
The National Institute of Health sees the value of genetic profiles and is funding additional research. Duke University was the first client to use Expression Analysis and collaborates with the FDA and pharma for electronic submissions of data in an effort to accelerate drugs and diagnostics though...
-
Last month several Genomics companies received warning letters from the State of California and were told they needed to be licensed. 23andMe, which is an offshoot of Google may have a potential solution on the dilemma of the licensing issue with working with LabCorp, one of the largest labs...
-
Yesterday I posted about Bank of American hiring more research analysts in the area of healthcare investing and and also stated that Blogs are now becoming part of the research process , I have found several who read this blog. This page relates back to a a post about the commitment of the DeCode...